A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration

A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration

John W Kitchens,1,* Nawal Kassem,2,* William Wood,1 Thomas W Stone,1 Rick Isernhagen,1 Edward Wood,1 Brad A Hancock,2 Milan Radovich,2,4 Josh Waymire,4 Lang Li,3,4 Bryan P Schneider2,41Ophthalmology, Retina Associates of Kentucky, Lexington, KY; 2Department of Medicine, Divisions of Hematology/Oncol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kitchens JW, Kassem N, Wood W, Stone TW, Isernhagen R, Wood E, Hancock BA, Radovich M, Waymire J, Li L, Schneider BP
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/a74d4a465efe434faf1d47ab8ba895cc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares